Literature DB >> 2767136

Muscarinic receptor binding characteristics of a human neuroblastoma SK-N-SH and its clones SH-SY5Y and SH-EP1.

D G Lambert1, A S Ghataorre, S R Nahorski.   

Abstract

The present study examines the muscarinic receptor binding characteristics of parent human neuroblastoma (SK-N-SH) and its neuroblast (SH-SY5Y) and epithelial-like (SH-EP1) clones using [3H]methylscopolamine [( 3H]NMS). Specific [3H]NMS binding to intact SK-N-SH and SH-SY5Y cells was saturable with a Kd of 0.2 nM and Bmax of 100-150 fmol/mg protein. Specific [3H]NMS binding to whole cell preparations of SH-EP 1 could not be detected. Pharmacological analysis of the binding site both in whole cells and membranes of SK-N-SH are indicative of an homogeneous receptor population possessing low affinity for the M1-selective antagonist pirenzepine. The muscarinic receptors expressed by the neuroblast clone, SH-SY5Y were further characterized and shown to have the properties of an homogeneous M3 subtype with low affinity for the M1-selective antagonist pirenzepine and the M2-cardioselective AFDX-116 but high affinity for 4-diphenylacetoxy-N-methyl piperidine methiodide (4-DAMP). In conclusion the SH-SY5Y neuroblastoma should provide an important human neuronal cell model with which to define the regulation of post-receptor events driven by a single receptor population.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2767136     DOI: 10.1016/0014-2999(89)90771-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  35 in total

1.  G(q/11) and G(i/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype.

Authors:  E C Akam; R A Challiss; S R Nahorski
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

Review 2.  The regulation of neurotransmitter secretion by protein kinase C.

Authors:  P F Vaughan; J H Walker; C Peers
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

3.  AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3.

Authors:  Taj D King; Ling Song; Richard S Jope
Journal:  Biochem Pharmacol       Date:  2006-03-10       Impact factor: 5.858

4.  Muscarinic receptor activation protects cells from apoptotic effects of DNA damage, oxidative stress, and mitochondrial inhibition.

Authors:  Patrizia De Sarno; Svetlana A Shestopal; Taj D King; Anna Zmijewska; Ling Song; Richard S Jope
Journal:  J Biol Chem       Date:  2003-01-21       Impact factor: 5.157

5.  Elevation of cytosolic calcium by cholinoceptor agonists in SH-SY5Y human neuroblastoma cells: estimation of the contribution of voltage-dependent currents.

Authors:  I D Forsythe; D G Lambert; S R Nahorski; P Lindsdell
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

6.  Coupling of muscarinic receptors to the mobilization of intracellular Ca2+ stores in permeabilized SH-SY5Y human neuroblastoma cells.

Authors:  R J Wojcikiewicz; S T Safrany; R A Challiss; J Strupish; S R Nahorski
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

7.  Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor.

Authors:  Mark R Dowling; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2006-07-10       Impact factor: 8.739

8.  Accumulation and metabolism of Ins(1,4,5)P3 and Ins(1,3,4,5)P4 in muscarinic-receptor-stimulated SH-SY5Y neuroblastoma cells.

Authors:  D G Lambert; R A Challiss; S R Nahorski
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

9.  SK & F 96365 inhibits carbachol-induced phosphoinositide turnover in human neuroblastoma SH-SY5Y and rat cerebellar granule cells.

Authors:  W W Lin; C W Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

10.  Muscarinic receptors coupled to phosphoinositide hydrolysis and elevated cytosolic calcium in a human neuroblastoma cell line SK-N-SH.

Authors:  J G Baird; D G Lambert; J McBain; S R Nahorski
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.